Conclusion
In conclusion, the results of our study demonstrate that ALDH1
positivity was associated with disease-related survival and RT
sensitivity. CD44 positivity did not differ between patients with and
without recurrence after RT. In our study, sample size is small and
needs to be done larger cohort studies for the powered the predictive
effects of these markers. For ALDH1 positivity to be used as a biomarker
when making treatment decisions, it is necessary to conduct studies with
a larger patient series and determine its correlation with other
biomarkers.